• No results found

Dry powder inhaler

ADVANCEMENTS IN DRY POWDER INHALER

ADVANCEMENTS IN DRY POWDER INHALER

... The dry powder inhaler (DPI) has become widely known as a very attractive platform for drug delivery. DPIs are being used for the treatment of asthma and chronic obstructive pulmonary disease by many ...

5

Recent advances in capsule-based dry powder inhaler technology

Recent advances in capsule-based dry powder inhaler technology

... Pulmonary drug delivery is currently the focus of accelerated research and development because of the potential to produce maximum therapeutic benefit to patients by directly targeting drug to the site of pathology in ...

7

Bronchodilator Response to Salbutamol Delivered by Metered Dose Inhaler with Spacer and Dry Powder Inhaler in Acute Asthma In Children: A Comparative Study

Bronchodilator Response to Salbutamol Delivered by Metered Dose Inhaler with Spacer and Dry Powder Inhaler in Acute Asthma In Children: A Comparative Study

... Background: Salbutamol inhalation is the mainstay of treatment for acute exacerbation of asthma. A number of delivery systems for asthma medication have been developed for children, each having its own advantages and ...

6

Comparative Analysis of Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) at Rural Bangladesh Perspective

Comparative Analysis of Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) at Rural Bangladesh Perspective

... the inhaler devices accessible are pressurized metered dose inhaler (pMDI), dry powder inhaler (DPI) which incorporate aerolizer, diskus, handihaler, rotahaler and so forth [4,5,6] ...

5

Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD

Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD

... furoate/vilanterol dry powder inhaler combination therapy has recently been approved by the US Food and Drug Administration and the European Medicines Agency as a new regular treatment for patients ...

8

Development and Validation of Analytical Method for Simultaneous Estimation of Formoterol Fumarate Dihydrate and Fluticasone Propionate from Bulk and Dry Powder Inhaler Formulation

Development and Validation of Analytical Method for Simultaneous Estimation of Formoterol Fumarate Dihydrate and Fluticasone Propionate from Bulk and Dry Powder Inhaler Formulation

... A method was developed and validated for analysis of Formoterol Fumarate and Fluticasone Propionate in dry powder inhaler formulations. Separation was achieved on a HiQ Sil C18HS, 250×4.6 mm, 5 µm ...

11

Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler

Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler

... pure powder, nanoparticles and agglomerate, equivalent to theophylline 80 mg, were separately placed into capsules suitable for the dry powder inhaler in order to test their aerodynamic ...

10

PAST AND PRESENT TRENDS OF DRY POWDER INHALER DEVICES: A REVIEW

PAST AND PRESENT TRENDS OF DRY POWDER INHALER DEVICES: A REVIEW

... Spinhaler is a single dose dry powder inhaler device produced by Aventis. Spinhaler, launched by Fisons in the late 1967. 15 It is similar to that of rotahaler which can allow one capsule at one ...

11

“Pharmacokinetic Study of Dry Powder Inhaler Formulations of Antiasthmatic Drugs” by Dhara P. Jain, Parag Vijay Jain, M. R. Bhalekar, India.

“Pharmacokinetic Study of Dry Powder Inhaler Formulations of Antiasthmatic Drugs” by Dhara P. Jain, Parag Vijay Jain, M. R. Bhalekar, India.

... a dry powder inhaler (DPI) of drug loaded poly (DL-lactide) and poly (DL-lactide/glycolide copolymer) microparticles and evaluate the selected formulations from in vitro studies by pulmonary drug ...

9

Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease

Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease

... Background: Effective bronchodilator therapy depends upon adequate drug deposition in the lung. COPD patients who are unable to administer medications efficiently with conventional inhalers may benefit from the use of a ...

12

A RAPID AND STABILITY INDICATING RP HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF TIOTROPIUM, FORMOTEROL AND CICLESONIDE IN A DRY POWDER INHALER

A RAPID AND STABILITY INDICATING RP HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF TIOTROPIUM, FORMOTEROL AND CICLESONIDE IN A DRY POWDER INHALER

... (FFD) 12 mcg Fig. 2 which causes bronchodilation by relaxing the smooth muscle in the airway so as to treat the exacerbation of asthma. And a non-halogenated glucocortico steroid Ciclesonide (CIC) 400 mcg Fig 3 which is ...

12

DRY POWDER INHALER; SPECIAL EMPHASIS TO FORMULATION, DEVICES, CHARACTERIZATION & PROCESS VALIDATION PROTOCOL: A REVIEW

DRY POWDER INHALER; SPECIAL EMPHASIS TO FORMULATION, DEVICES, CHARACTERIZATION & PROCESS VALIDATION PROTOCOL: A REVIEW

... The dry powder inhaler device is paramount to the triumph of a DPI product. It is the medium the formulation is delivered through for local or systemic effect via pulmonary the route. The thriving ...

5

Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study

Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study

... Mometasone furoate administered via a dry powder inhaler (MF-DPI) has been shown to be effective in treating asthma, as shown in comparative studies with other ICSs [14-18]. Although early studies of ...

9

PREPARATION AND CHARECTERIZATION OF PRONIOSOMAL DRY POWDER INHALER OF BUDESONIDE USING LACTOSE CARRIER FOR NASAL ADMINISTRATION

PREPARATION AND CHARECTERIZATION OF PRONIOSOMAL DRY POWDER INHALER OF BUDESONIDE USING LACTOSE CARRIER FOR NASAL ADMINISTRATION

... All Dry Powder Inhaler (DPI) consist of a powder formulation and an inhalation ...The powder formulation is composed of a micronised drug powder, either alone or in combination ...

19

Dose–response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT)

Dose–response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT)

... Introduction: An extrafine formulation of the long-acting muscarinic antagonist, glycopyrronium bromide (GB), has been developed for delivery via the NEXThaler dry powder inhaler (DPI). This study ...

11

Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment

Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment

... correct inhaler technique for Pulmicort® Turbuhaler versus pMDIs, 64% of patients preferred Pulmicort Turbuhaler over pMDIs since it was not associated with a ‘bad’ aftertaste ...current inhaler and patient ...

11

Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older

Ease-of-use preference for the ELLIPTA<sup>&reg;</sup> dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-na&iuml;ve Japanese volunteers aged 40 years or older

... the inhaler was then made and the assessor again recorded any ...the inhaler correctly even at the second attempt were provided with verbal handling instruction, and the mean time from start of handling ...

11

Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD

Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD

... current scientific literature about patient perception of the inhaler. The airflow resistance of the ELLIPTA DPI has however been extensively studied in vitro. In a quan- titative study, using an Electronic Lung™ ...

14

Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters

Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters

... to a pneumotachograph (Spiromaster MX, Medikro Ltd, Kuopio, Finland; Figure 1). The patients were instructed to exhale gently (to functional residual capacity) and then to inhale as fast and long as possible through the ...

6

Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma

Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma

... metered-dose inhaler was provided at the screening visit and enrollees were instructed to use it as needed, before exercise, and before exposure to potential triggers (eg, ani- ...

7

Show all 4130 documents...

Related subjects